Literature DB >> 32929608

Risk factors for right ventricular dysfunction in patients with lymphangioleiomyomatosis.

Wei Hua1, Wenbo Yang1, Jianing Gu1, Jialiang Wu2, Wei Wang2, Yanpu Liu2, Hong Zhu2, Min Zhou3, Jieming Qu4, Yuehua Fang1.   

Abstract

Lymphangioleiomyomatosis (LAM) is a rare disease characterized by diffuse cystic lesions of the lung. The present study was designed to evaluate the right ventricular (RV) function in LAM patients via single-beat real-time three-dimensional echocardiography (RT-3DE) and to investigate the factors affecting RV function in LAM patients. According to tricuspid regurgitation velocity (TRV), forty-five female LAM patients [(44.07 ± 10.22) years old] were divided into TRV ≤ 2.8 m/s group (n = 29) and TRV > 2.8 m/s group (n = 16). Relative echocardiography parameters were assessed by conventional transthoracic echocardiography, Doppler tissue imaging (DTI) and RT-3DE, respectively. Pulmonary function tests and the six-minute walk tests (SMWT) were also performed for LAM patients. We found that most of RV functional parameters in LAM patients were worse than that in control patients, although left ventricular dysfunction was not significantly observed. Correlation analysis showed that 3D echocardiographic RV ejection fraction (RVEF) was negatively correlated with pulmonary vascular resistance (PVR), TRV, and the decrease of oxygen saturation (SpO2) post SMWT, and positively correlated with Forced expiratory volume in the first second/forced vital capacity, carbon monoxide diffusion predicted value, SMWT distance, and resting SpO2 in LAM patients. Multivariate stepwise linear regression analysis showed that PVR and SpO2 before SMWT were independent influence factors of RVEF in LAM patients. In this study, we found that RV dysfunction was presented in LAM patients, although left ventricular dysfunction was not significantly obvious. The main influence factors of RVEF were PVR and hypoxia. RT-3DE is a low-cost and noninvasive way to evaluate RV function in LAM patients.

Entities:  

Keywords:  Echocardiography; Hypoxemia; Lymphangioleiomyomatosis; Pulmonary hypertension; Pulmonary vascular resistance; Right ventricular function

Mesh:

Year:  2020        PMID: 32929608     DOI: 10.1007/s10554-020-02009-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  23 in total

Review 1.  The changing face of a rare disease: lymphangioleiomyomatosis.

Authors:  Sergio Harari; Olga Torre; Roberto Cassandro; Joel Moss
Journal:  Eur Respir J       Date:  2015-09-24       Impact factor: 16.671

Review 2.  Forgotten No More: A Focused Update on the Right Ventricle in Cardiovascular Disease.

Authors:  Myriam Amsallem; Olaf Mercier; Yukari Kobayashi; Kegan Moneghetti; Francois Haddad
Journal:  JACC Heart Fail       Date:  2018-10-10       Impact factor: 12.035

3.  CTLA4 blockade promotes vessel normalization in breast tumors via the accumulation of eosinophils.

Authors:  Xichen Zheng; Naidong Zhang; Long Qian; Xuexiang Wang; Peng Fan; Jiajie Kuai; Siyang Lin; Changpeng Liu; Wen Jiang; Songbing Qin; Haifeng Chen; Yuhui Huang
Journal:  Int J Cancer       Date:  2019-12-28       Impact factor: 7.396

4.  Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension.

Authors:  Janne Mykland Hilde; Ingunn Skjørten; Ole Jørgen Grøtta; Viggo Hansteen; Morten Nissen Melsom; Jonny Hisdal; Sjur Humerfelt; Kjetil Steine
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

5.  Echocardiographic abnormalities in patients with COPD at their first hospital admission.

Authors:  Xavier Freixa; Karina Portillo; Carles Paré; Judith Garcia-Aymerich; Federico P Gomez; Marta Benet; Josep Roca; Eva Farrero; Jaume Ferrer; Carlos Fernandez-Palomeque; Josep M Antó; Joan Albert Barberà
Journal:  Eur Respir J       Date:  2012-09-27       Impact factor: 16.671

6.  The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15-Year Prospective Longitudinal Analysis.

Authors:  Nishant Gupta; Hye-Seung Lee; Jay H Ryu; Angelo M Taveira-DaSilva; Gerald J Beck; Jar-Chi Lee; Kevin McCarthy; Geraldine A Finlay; Kevin K Brown; Stephen J Ruoss; Nilo A Avila; Joel Moss; Francis X McCormack
Journal:  Chest       Date:  2018-06-22       Impact factor: 9.410

7.  Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis.

Authors:  Belinda N Rivera-Lebron; Paul R Forfia; Maryl Kreider; James C Lee; John H Holmes; Steven M Kawut
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

8.  Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

Authors:  Francis X McCormack; Nishant Gupta; Geraldine R Finlay; Lisa R Young; Angelo M Taveira-DaSilva; Connie G Glasgow; Wendy K Steagall; Simon R Johnson; Steven A Sahn; Jay H Ryu; Charlie Strange; Kuniaki Seyama; Eugene J Sullivan; Robert M Kotloff; Gregory P Downey; Jeffrey T Chapman; MeiLan K Han; Jeanine M D'Armiento; Yoshikazu Inoue; Elizabeth P Henske; John J Bissler; Thomas V Colby; Brent W Kinder; Kathryn A Wikenheiser-Brokamp; Kevin K Brown; Jean F Cordier; Cristopher Meyer; Vincent Cottin; Jan L Brozek; Karen Smith; Kevin C Wilson; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

Review 9.  Lymphangioleiomyomatosis.

Authors:  Simon R Johnson; Angelo M Taveira-DaSilva; Joel Moss
Journal:  Clin Chest Med       Date:  2016-09       Impact factor: 2.878

Review 10.  Pulmonary hypertension and right heart dysfunction in chronic lung disease.

Authors:  Amirmasoud Zangiabadi; Carmine G De Pasquale; Dimitar Sajkov
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

View more
  1 in total

1.  Reliability and feasibility of automated function imaging for quantification in patients with left ventricular dilation: comparison with cardiac magnetic resonance.

Authors:  Yefen Chen; Wei Hua; Wenbo Yang; Zhongwei Shi; Yuehua Fang
Journal:  Int J Cardiovasc Imaging       Date:  2022-01-03       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.